Jonathan E. Lim

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jessica Oien, Attorney-in-Fact for Jonathan E. Lim
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jonathan E. Lim

Form 4 holding Chairman & CEO, Director, 10%+ Owner

Erasca, Inc.

Security class
Stock option (right to buy)
Shares / value
2,000,000
Estimated value
Report date
29 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Maze Therapeutics, Inc.

Security class
Common Stock
Shares / value
307,956
Estimated value
Report date
03 Feb 2025
Price
Ownership
City Hill, LLC
Form 4 holding Director

Boundless Bio, Inc.

Security class
Stock Option (right to buy)
Shares / value
48,000
Estimated value
Report date
15 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Maze Therapeutics, Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
03 Feb 2025
Price
Ownership
City Hill, LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Maze Therapeutics, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
03 Feb 2025
Price
Ownership
City Hill, LLC
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jonathan E. Lim

4 ERAS

Erasca, Inc.

Report period
20 Jul 2021
Transactions
6
Transaction value
$0
Accepted by SEC
20 Jul 2021, 20:58
Role
Chairman and Chief Executive Officer, Director, 10%+ Owner
Next action
Open filing details
3 ERAS

Erasca, Inc.

Report period
15 Jul 2021
Transactions
0
Transaction value
$0
Accepted by SEC
15 Jul 2021, 21:32
Role
Chairman and CEO Exhibit List: 24 - Power of Attorney, Director, 10%+ Owner
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .